Marie Skłodowska-Curie Actions
MHH life scientists were successfull with nine Actions in “Horizon 2020”.
Individual Fellowships
MPN2AML (Global Fellowship)
Identification of novel genetic regulators governing leukaemic transformation from myeloid proliferative neoplasms
Fellow: Dr. Alban A. Johansson, Clinic for Hematology, Hemostasiology, Oncology, and Cell Therapy
Duration: 01.09.2026 – 31.08.2029
Innovative Training Networks - with coordination at the MHH
MATURE-NK
MAnufacturing of TUmour-REactive Nature Killer cells
Coordinator: Prof. Dr. Ulrike Köhl, IFB-Tx
Duration: 01.06.2018 - 30.11.2022
Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects
Coordinator: Prof. Dr. Peter Claus, Institute of Neuroanatomy and Cell Biology
until 30.09.2022 coordinated at the MHH, since 01.10.2022 coordinated by SMATHERIA
Duration: 01.10.2020 - 30.09.2024
Innovative Training Networks - with participation of the MHH
Comm4Child
Communication for Children with Hearing Impairment to optimise Language Development
Partner: Prof. Dr. Andrej Kral, Clinic for Ear, Nose and Throat Medicine, VIANNA
Duration: 01.02.2020 - 31.05.2024
Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology
Partner: Prof. Dr. Beate Sodeik, Institute of Virology
Duration: 01.05.2016 - 30.10.2020
Towards more patients safety by a novel combination of imaging technologies for in-novation of
biodegradable magnesium implants
Partner: Dr. Martin Meier, Institute for Laboratory Animal Science and Central Animal Laboratory
Duration: 01.10.2018 - 30.09.2022
Development and disease of the renal tract
Partner: Prof. Dr. Andreas Kispert, Institute of Molecular Biology
Duration: 01.06.2015 - 31.05.2019
TRAIN-HEART
Partner: Prof. Dr. Dr. Thomas Thum, Institute for Molecular and Translational Therapeutic Strategies
Duration: 01.06.2019 - 31.08.2023
Research and Innovation Staff Exchange (RISE)
miRNA-DisEASY
microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis
Partner: Prof. Dr. Jürgen Borlak, Institute for Pharmaco- and Toxicogenomics Research
Duration: 01.12.2015 - 30.11.2019 (MHH involved since February 2017)
Individual Fellowships
POSEIDON
Novel bioreactor Platform for reprOducible, Scalable ExpansIon and cardiac DifferentiatiON of hiPSC in suspension culture
Fellow: Dr. Diana Massai, Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery
Duration: 01.10.2015 - 31.08.2017
Contact
Overview of our contact persons